Log In
Print this Print this

Rulide, roxithromycin

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionSemi-synthetic macrolide antibiotic
Molecular Target
Mechanism of ActionRibosomal 50S subunit inhibitor
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentMarketed
Standard IndicationBacterial infection
Indication DetailsTreat bacterial infections
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today